Author

Z. Aktary

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

L. Larue· 3 shared F. Rambow· 2 shared I. Davidson· 2 shared V. Delmas· 2 shared V. Petit· 2 shared A. Bellacosa· 1 shared A. Conde· 1 shared A. Sarasin· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

L. Larue

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintDec 2, 2022

The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma

J. H. Raymond, M. Schonau, V. Petit…·V. Delmas

This study identifies an E-cadherin-ER-GRPR axis that drives sex-specific melanoma metastasis and shows GRPR inhibition reduces metastasis in vivo.

DOI 10.1101/2022.12.02.518844

mouseexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivPreprintJan 13, 2021

Dynlt3, a novel fundamental regulator of melanosome movement, distribution, maturation and transfer

Z. Aktary, A. Conde, F. Rambow…·L. LARUE

This study identifies Dynlt3 as a critical regulator of melanosome transport, maturation, and transfer in melanocytes, revealing its role in skin pigmentation through interactions with the Wnt/β-catenin pathway.

DOI 10.1101/2021.01.13.426541

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivJan 13, 2021

BRN2 is a non-canonical melanoma tumor-suppressor

M. Hamm, P. Sohier, V. Petit…·L. Larue

This study identifies BRN2 as a non-canonical tumor suppressor in melanoma, showing its role in initiation and progression through PTEN regulation and PI3K signaling.

DOI 10.1038/s41467-021-23973-5

𝕏 PostBluesky